Directory  |   Consumers  |   FAQ  

NPRA Banner

               
Product Search   QUEST3+ System   Enquiries   Sitemap  

Reaksi Drug Safety News 2017 - Issue 6/2017

Hits: 21044

User Rating: 1 / 5

Star ActiveStar InactiveStar InactiveStar InactiveStar Inactive
 

Reaksi Drug Safety News 2017,

Issue 6/2017

 

  • Ketamine: Risk of Severe Liver Damage with Repeated and/or Prolonged Use at High Doses
  • Recombinant Human Erythropoietins: Risk of Severe Cutaneous Adverse Reactions (SCARs)

 



 		  
  DOWNLOAD PDF

 

 

 


  Reaksi Archive

Rating:
( 1 Rating )

 

National Pharmaceutical Regulatory Agency (NPRA)

Lot 36, Jalan Universiti (Jalan Prof Diraja Ungku Aziz), 46200 Petaling Jaya, Selangor, Malaysia.

  • Phone: +603-7883 5400

 

 

More Links

Our Location

Public Enquiry

Privacy & Policy

Archives

More Links

DISCLAIMER

The Government of Malaysia and the National Pharmaceutical Regulatory Agency are not responsible for any loss or damage caused by the usage of any information obtained from this website.

Mobile Web :

NPRA Product StatusNPRA Product Status

NPRA Product Status

Site Last Modified

  • Last Modified: Wednesday 20 November 2024, 15:49:08.

Online Services

Search

Main Menu English

Choose Your Language